Lv11
30 积分 2022-10-28 加入
Development of Commercial-Ready Processes for Antibody Drug Conjugates
1小时前
待确认
Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates
1小时前
已完结
Considerations for Starting Material Designation for Drug-Linkers in Antibody–Drug Conjugates
2小时前
已完结
Simplified strategy for developing purification processes for antibody-drug conjugates using cation-exchange chromatography in flow-through mode
1个月前
已完结
Small molecule clearance in ultrafiltration/diafiltration in relation to protein interactions:Study of citrate binding to a Fab
3个月前
已完结
Efficiency of ultrafiltration/diafiltration in removing organic and elemental process equipment related leachables from biological therapeutics
3个月前
已完结
Strategies for UF/DF-Based Impurity Removal in the Post-conjugation Purification of Antibody–Drug Conjugates
3个月前
已完结
皖公网安备34019202002308
